On October 29, Wu Qingwen, Deputy Secretary of the Municipal Party Committee and Mayor, presided over the 12th Suzhou City's 'Direct Business Assistance' government-enterprise symposium, focusing on the development of the new materials industry, communicating face-to-face with enterprises, carefully listening to opinions, suggestions and demands, and studying solutions on-site. Wu Qingwen emphasized that it is necessary to target major national needs, strengthen policy support and institutional innovation, help enterprises become bigger and stronger, and accelerate the high-quality development of the new materials industry. Professor Chen Hong, founder and chairman of Besaifei, attended the conference.
At the meeting, Besaifei communicated and interacted with the heads of 10 companies in the new materials field in Suzhou, including Nanda Optoelectronics, NanoVis Technology, Tongli Optoelectronics, New Micron, Nofi Nano, Hanna Materials, Navitas Technology, Sino-Xinrui, and C&K Semiconductor. They exchanged and interacted with each other on industry development trends and future development of enterprises, and put forward specific demands and suggestions on issues such as element guarantees, business environment, and government approvals. Relevant departments and local responsible persons responded to the demands raised by the enterprises.
# About Baisaifei
Jiangsu Baisaifei Biotechnology Co., Ltd. is the leading domestic technical service platform for the entire industry chain of medical functional coatings, and is a leading enterprise and leader in the field of medical coatings. Based on the founder's more than 20 years of professional accumulation in the field of biomaterial surface interfaces and academic influence at home and abroad, it focuses on innovative research and development of biomaterial surface modification technology, and develops high-end functional coatings and related products with independent intellectual property rights and international competitiveness. Since its establishment in 2017, the company has gone through several expansions and four rounds of financing, and now has nearly 30,000 square meters of R&D and production space. It has cooperated with hundreds of medical device companies, including domestic and foreign listed companies and group companies, and assisted companies to obtain a large number of Class II and Class III medical device registration certificates, covering neurological intervention, cardiovascular intervention, non-vascular intervention, drainage, intravascular implantation, extracorporeal life support and other fields. Coating equipment and high-capacity coating production lines are sold at home and abroad.
Coating categories include hydrophilic lubricating coatings, anticoagulant coatings, hydrophilic lubricating antibacterial coatings, hydrophobic coatings, anti-crystallization coatings, anti-fouling coatings, drug-releasing coatings, etc. The cooperation model includes coating liquid sales, coating equipment and coating testing instrument sales, coating ODM, coating inspection and testing, and coating customized R&D services.
According to public data from the State Intellectual Property Office, Baisaifei has become the company with the most applications and authorized patents in China in the global medical coating industry. It has also participated in a number of regulatory scientific research and the establishment of inspection and testing standards related to coated medical devices. It has formed a biomaterial surface modification technology as the core, integrating the research and development and production of coating materials, A comprehensive technical service and innovative product platform integrating advanced manufacturing of coating equipment, coating process development and customization, coating quality analysis instrument development and inspection and testing services, and research and development of new coated products, to create an internationally leading brand of independent and controllable biological functional coatings and related products, and promote the high-quality development of the health industry.
